Li Wensheng, Wen Weixing, Xie Dongxiao, Qiu Min, Cai Xiaoyan, Zheng Sulin, Huang Yuli
Department of Cardiology, Shunde Hospital, Southern Medical University (the First People's Hospital of Shunde), Foshan, China.
Department of Scientific Research and Education, Shunde Hospital, Southern Medical University (the First People's Hospital of Shunde), Foshan, China.
Ther Adv Chronic Dis. 2022 Aug 23;13:20406223221119626. doi: 10.1177/20406223221119626. eCollection 2022.
Recent research has associated non-alcoholic fatty liver disease (NAFLD) with an increased risk of atherosclerotic cardiovascular disease. Previous studies that evaluated the association between NAFLD and risk of heart failure (HF) yielded inconsistent results, however. This meta-analysis aimed to evaluate the association between NAFLD and the risk of HF.
We searched multiple electronic databases, including PubMed, Google Scholar, Embase and Web of Science for potential studies published from inception until 30 October 2021. Cohort studies reported multivariable-adjusted risks of incident HF in NAFLD patients comparing those without NAFLD were included.
Six cohort studies comprising 10,979,967 participants (women = 55.5%) were included in the study. The median prevalence of NAFLD in these studies was 22.2%. During a median follow-up duration of 7.0 years, 92,915 HF cases were detected. In the unadjusted model, patients with NAFLD had a greater risk of incident HF [random-effect hazard ratio (HR) = 1.47, 95% confidence interval (CI) = 1.25-1.75, = 99%], compared with those without NAFLD. After multivariable adjustment of confounding risk factors, NAFLD was still linked with a higher risk of HF incidence (random-effect HR = 1.36, 95% CI = 1.16-1.58, = 98%). The risk of HF was increased not only in patients with progressive NAFLD severity but also in those with simple steatosis. The absolute risk difference of HF in NAFLD patients compared with those without NAFLD was 11.0 (95% CI = 4.9-17.7) per 10,000 person-years after multivariable adjustment.
This meta-analysis suggests that NAFLD may be associated with an increased risk of incident HF. Owing to the high heterogeneity of the published studies, however, further high-quality studies are still needed.
近期研究表明,非酒精性脂肪性肝病(NAFLD)与动脉粥样硬化性心血管疾病风险增加有关。然而,先前评估NAFLD与心力衰竭(HF)风险之间关联的研究结果并不一致。本荟萃分析旨在评估NAFLD与HF风险之间的关联。
我们检索了多个电子数据库,包括PubMed、谷歌学术、Embase和科学网,以查找从数据库建立至2021年10月30日发表的相关潜在研究。纳入了队列研究,这些研究报告了非NAFLD患者与NAFLD患者相比发生HF的多变量调整风险。
该研究纳入了6项队列研究,共10979967名参与者(女性占55.5%)。这些研究中NAFLD的中位患病率为22.2%。在中位随访7.0年期间,共检测到92915例HF病例。在未调整模型中,与非NAFLD患者相比,NAFLD患者发生HF的风险更高[随机效应风险比(HR)=1.47,95%置信区间(CI)=1.25 - 1.75,I² = 99%]。在对混杂风险因素进行多变量调整后,NAFLD仍与HF发病风险较高相关(随机效应HR = 1.36,95% CI = 1.16 - 1.58,I² = 98%)。不仅在NAFLD严重程度进展的患者中,而且在单纯性脂肪变性患者中,HF风险均增加。多变量调整后,NAFLD患者与非NAFLD患者相比,每10000人年HF的绝对风险差异为11.0(95% CI = 4.9 - 17.7)。
本荟萃分析表明,NAFLD可能与HF发病风险增加有关。然而,由于已发表研究的高度异质性,仍需要进一步的高质量研究。